But members of FDA's Office of New Drugs, which approved Avandia in the first place, were more circumspect."It depends on how you crunch this data," he said. Still, the data were solid enough that the advisory committee voted 20 to 3 that Avandia boosts the risk of heart disease in type 2 diabetes....